Pfizer pledges to provide 23 drugs at not-for-profit prices to lower income countriesBMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1329 (Published 26 May 2022) Cite this as: BMJ 2022;377:o1329
- Janice Hopkins Tanne
- New York
The drug company Pfizer has said it will provide all its current patent protected medicines and vaccines that are available in the US and EU to 1.2 billion people in lower income countries on a not-for-profit basis.1
The company announced its “Accord for a Healthier World” at the World Economic Forum in Davos, Switzerland, on 25 May. But it met criticism as being “too little, too late.” Pfizer and other vaccine makers have been criticised by global health advocates and officials in low and middle income countries for supplying more vaccines to richer countries.
Pfizer said it will provide 23 medicines and vaccines for treating infectious diseases, some cancers, and rare and inflammatory diseases to 45 …